Filing Details
- Accession Number:
- 0001140361-15-019188
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-12 18:44:42
- Reporting Period:
- 2015-05-08
- Filing Date:
- 2015-05-12
- Accepted Time:
- 2015-05-12 18:44:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293818 | Opgen Inc | OPGN,OPGNW | Services-Medical Laboratories (8071) | 061614015 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1641535 | Timothy Howe | 1055 Washington Boulevard Stamford CT 06901 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-05-08 | 12,500 | $6.00 | 68,317 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2015-05-08 | 320,011 | $0.00 | 388,328 | No | 4 | C | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
No | 4 | C | Indirect | See footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Redeemable Convertible Preferred Stock | Disposition | 2015-05-08 | 320,011 | $0.00 | 320,011 | $0.00 |
Common Stock | Warrants | Acquisiton | 2015-05-08 | 12,500 | $0.00 | 12,500 | $6.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | 2015-05-08 | 2020-05-08 | No | 4 | P | Indirect |
Footnotes
- Series A Redeemable Convertible Preferred Stock automatically converted into common stock on a 1-to-1 basis upon the consummation of the Company's initial public offering.
- The securities are directly held by CHL Medical Partners III, L.P. and CHL Medical Partners III Side Fund, L.P. (collectively, the "CHL Medical Partners Funds"). Mr. Howe is an officer of the General Partner of CHL Medical Partners Funds, and may be deemed to have shared voting and dispositive power over the shares owned by CHL Medical Partners Funds. Mr. Howe disclaims beneficial ownership of all shares held by CHL Medical Partners Funds, except to the extent of his actual pecuniary interest therein.